Clinical Trial Update: Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating landiolol, a beta-blocker, in out-of-hospital cardiac arrest across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest

Drugs mentioned

• LANdiolol (landiolol hydrochloride)

Snippet

Sponsor: Medical University of Vienna | Conditions: Cardiac Arrest | Phase 1, Phase 2 | Status: UNKNOWN